ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

Biogen ( NASDAQ: BIIB) and Stoke Therapeutics ( NASDAQ: STOK) said on Tuesday they are collaborating to develop and ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

The partnership splits the rights to Stoke’s epilepsy antisense oligonucleotide, with up to $385 million in potential ...

Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.

Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet ...

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Don’t be mistaken, despite the album title of Lucky Girl Syndrome, Journey Montana’s position in the music world is a well-earned one. Lucky Girl Syndrome delivers a contemporary blend of pop ...

THE 22 YEAR OLD’S JOURNEY BEGAN WHEN THE PANDEMIC DID ... AND THEY LED ME THROUGH THE PROCESS OF GETTING ACCEPTED AS A PATIENT AND FROM WALKING IN THE DOOR, I JUST FELT VERY ACCEPTED AND ...

Here, we speak with Dr Simone Seiter from IMS Health to hear how putting the patient journey at the centre is the key to providing the most accurate market research. Market research has always ...